Albany, NY -- (SBWIRE) -- 11/27/2016 -- Nutraceuticals are defined as the food and dietary substances which help lower the TC (total cholesterol) levels of the body. It functions by triggering the cholesterol inhibiting hormones of the body and thereby restoring homeostasis and preventing coronary heart diseases. Nutraceuticals are currently preferred more than general cholesterol lowering medications. The cholesterol lowering nutraceuticals ingredient market bears two major segmentations, on the basis of types into: beta glucans, soluble fibers, omega 3 fatty acids, plant sterols, soy foods and others, and on the basis of geography into: the North American, European, Asia Pacific and rest of the world regions.
Download exclusive Sample of this report:
The European cholesterol lowering nutraceuticals ingredient market holds majority of the market share closely followed by the North American market. The Asia Pacific market also holds immense growth opportunities owing to its emerging nations. Japan leads the market in terms of market share in the Asia Pacific region.
Rising number of coronary heart diseases caused by elevated cholesterol levels, rising world obesity prevalence, increasing awareness amongst consumers in terms of realizing the toxic nature and side effects of medicines, increasing adoption of preventive medications are some of the factors driving the market. However, the growth of the market is slightly impeded by lack of availability of certified nutraceuticals drugs in the market. The fact that the demand side for cholesterol lowering nutraceuticals ingredient exceeds the supply side will fuel the growth of the market in the future.
View exclusive Global strategic Business report :
Some of the key players in the cholesterol lowering nutraceuticals ingredient market are: Valio Oy, Aarhus United A/S, Minerva, Arizona Chemicals, Coca Cola, Cargill, Cognis Nutrition and Health, Abitec Corporation, Unilever, Danone, Novartis, Angel Technology and others.